Gilbert & Cook’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,841
Closed -$262K 217
2023
Q2
$262K Sell
4,841
-2,407
-33% -$126K 0.04% 182
2023
Q1
$363K Sell
7,248
-4,033
-36% -$190K 0.06% 142
2022
Q4
$522K Buy
11,281
+35
+0.3% +$1.52K 0.1% 98
2022
Q3
$472K Buy
11,246
+289
+3% +$11.6K 0.1% 107
2022
Q2
$408K Buy
10,957
+1,011
+10% +$41.2K 0.07% 122
2022
Q1
$441K Buy
+9,946
New +$431K 0.07% 127
2020
Q4
Sell
-7,258
Closed -$277K 189
2020
Q3
$277K Buy
7,258
+239
+3% +$9.21K 0.07% 120
2020
Q2
$246K Buy
7,019
+636
+10% +$22.9K 0.06% 125
2020
Q1
$208K Buy
6,383
+180
+3% +$7.03K 0.06% 111
2019
Q4
$280K Buy
6,203
+693
+13% +$29K 0.07% 110
2019
Q3
$224K Buy
+5,510
New +$233K 0.06% 104
2017
Q3
Sell
-8,596
Closed -$239K 101
2017
Q2
$239K Buy
+8,596
New +$228K 0.08% 115

Other funds holding BSX

Gilbert & Cook's BSX Position: Q3 2023 in Review

Gilbert & Cook sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 4,841 shares — an estimated $262K sold.

Gilbert & Cook first reported a position in BSX in Q2 2017 and held it in 12 quarters. The position peaked at $522K in Q4 2022. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Gilbert & Cook reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • Gilbert & Cook sold 4,841 Boston Scientific shares in Q3 2023, an estimated $262K.
  • Gilbert & Cook first reported a position in Boston Scientific in Q2 2017 and held it in 12 quarters.
  • Gilbert & Cook's Boston Scientific position peaked at $522K in Q4 2022.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Gilbert & Cook's 13F filing for Q3 2023, filed 2 Nov 2023.